Logo
Oladoctor – online healthcare marketplace in Spain

Medicamentos con immunoglobulins, normal human, for intravascular adm. en Spain

F
FLEBOGAMMA DIF 100 mg/ml SOLUTION FOR INFUSION
Dosage form:  INJECTABLE PERFUSION, 100 mg/ml
Active substance:  immunoglobulins, normal human, for intravascular adm.
Manufacturer:  Instituto Grifols S.A.
Prescription required
FLEBOGAMMA DIF 100 mg/ml SOLUTION FOR INFUSION
Dosage form:  INJECTABLE PERFUSION, 100 mg/ml
Active substance:  immunoglobulins, normal human, for intravascular adm.
Manufacturer:  Instituto Grifols S.A.
Prescription required
FLEBOGAMMA DIF 100 mg/ml SOLUTION FOR INFUSION
Dosage form:  INJECTABLE PERFUSION, 100 mg/ml
Active substance:  immunoglobulins, normal human, for intravascular adm.
Manufacturer:  Instituto Grifols S.A.
Prescription required
FLEBOGAMMA DIF 50 mg/ml SOLUTION FOR INFUSION
Dosage form:  INJECTABLE PERFUSION, 50 mg/ml
Active substance:  immunoglobulins, normal human, for intravascular adm.
Manufacturer:  Instituto Grifols S.A.
Prescription required
FLEBOGAMMA DIF 50 mg/ml SOLUTION FOR INFUSION
Dosage form:  INJECTABLE PERFUSION, 50 mg/ml
Active substance:  immunoglobulins, normal human, for intravascular adm.
Manufacturer:  Instituto Grifols S.A.
Prescription required
FLEBOGAMMA DIF 50 mg/ml SOLUTION FOR INFUSION
Dosage form:  INJECTABLE PERFUSION, 50 mg/ml
Active substance:  immunoglobulins, normal human, for intravascular adm.
Manufacturer:  Instituto Grifols S.A.
Prescription required
FLEBOGAMMA DIF 50 mg/ml SOLUTION FOR INFUSION
Dosage form:  INJECTABLE PERFUSION, 50 mg/ml
Active substance:  immunoglobulins, normal human, for intravascular adm.
Manufacturer:  Instituto Grifols S.A.
Prescription required
FLEBOGAMMA DIF 50 mg/ml SOLUTION FOR INFUSION
Dosage form:  INJECTABLE PERFUSION, 50 mg/ml
Active substance:  immunoglobulins, normal human, for intravascular adm.
Manufacturer:  Instituto Grifols S.A.
Prescription required
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.
Follow us on social media